Lisa M. Harlan
View detailed information about Lisa M. Harlan, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Pharmaceutical Quality Operations I.
Documents (38)
- WARNING LETTER · US Specialty Formulations, LLC · April 26, 2022
- WARNING LETTER · atlantic management resources ltd · August 10, 2022
- WARNING LETTER · Stokes Healthcare Inc. dba Epicur Pharma · October 25, 2023
- WARNING LETTER · National Chemical Laboratories · May 26, 2023
- WARNING LETTER · Jamol Laboratories, Inc. · January 12, 2023
- UNTITLED LETTER · Stokes Healthcare Inc.
- WARNING LETTER · Safecor Health, LLC · March 16, 2023
- WARNING LETTER · New England Life Care, Inc. dba Advanced Compounding Solutions · April 28, 2022
- WARNING LETTER · Northern VA Compounders PLLC · December 9, 2022
- WARNING LETTER · Sure-Biochem Laboratories, LLC · October 7, 2022
- WARNING LETTER · EyePoint Pharmaceuticals, Inc. · February 15, 2024
- WARNING LETTER · Diamond Chemical Co., Inc. · May 16, 2024
- WARNING LETTER · Aerosol and Liquid Packaging, Inc. · December 18, 2023
- WARNING LETTER · Curexa - East, LLC dba Curexa · September 9, 2022
- WARNING LETTER · LS Promotions Inc. · May 2, 2024
- WARNING LETTER · Urban Electric Power · July 28, 2022
- WARNING LETTER · Safe Chain Solutions, LLC · May 11, 2022
- WARNING LETTER · Velocity Pharma LLC · December 14, 2023
- WARNING LETTER · Chemical Services Group, Inc./Royal Chemical Company · November 8, 2022
- WARNING LETTER · Omega Packaging Corp · November 17, 2022
- WARNING LETTER · Clean Solutions LLC · May 10, 2024
- WARNING LETTER · Denison Pharmaceuticals, LLC · February 9, 2023
- WARNING LETTER · southern tier home infusion, inc. · November 30, 2022
- 483 RESPONSE · SCA Pharmaceuticals, LLC · October 20, 2023
- 483 RESPONSE · CareFirst Specialty Pharmacy LLC · November 30, 2022
- 483 RESPONSE · Emergent Manufacturing Operations Baltimore LLC. · April 20, 2021
- UNTITLED LETTER · Stokes Healthcare Inc. dba Epicur Pharma · October 2, 2020
- STATE REFERRAL LETTER · sentara enterprises · July 6, 2023
- STATE REFERRAL LETTER · Maimonides Medical Center - Pharmacy · February 14, 2023
- STATE REFERRAL LETTER · CareFirst Specialty Pharmacy LLC · November 22, 2022
- WARNING LETTER · Central Admixture Pharmacy Services, Inc. · March 30, 2023
- WARNING LETTER · Greco Gas, Inc. · April 5, 2024
- WARNING LETTER · Delsam Pharma LLC · March 24, 2023
- WARNING LETTER · EzriCare LLC · March 21, 2023
- WARNING LETTER · RemedyRepack, Inc. · November 10, 2022
- WARNING LETTER · QuVa Pharma, Inc. · October 14, 2022
- WARNING LETTER · B & J Group · March 14, 2023
- WARNING LETTER · ImprimisRx NJ · August 5, 2022
Related Office
Person Information
Name
Lisa M. Harlan
Title
Program Division Director
Role
Regulatory Personnel
ID: e5d04349-6dd6-4f08-b31f-bf719c8413ab
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.